Deferred Tax Assets, Operating Loss Carryforwards of Dianthus Therapeutics, Inc. /DE/ from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Dianthus Therapeutics, Inc. /DE/ Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2025 was $132,723,000, a 21% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $132,723,000 +$23,063,000 +21% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q4 2024 $109,660,000 +$36,080,000 +49% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q4 2023 $73,580,000 +$68,197,000 +1267% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q4 2022 $5,383,000 +$732,000 +16% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q4 2021 $4,651,000 -$45,307,000 -91% 31 Dec 2021 8-K 21 Dec 2023
Q4 2020 $49,958,000 +$29,122,000 +140% 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q4 2019 $20,836,000 +$9,730,000 +88% 31 Dec 2019 10-K 03 Mar 2021 2020 FY
Q4 2018 $11,106,000 +$5,948,000 +115% 31 Dec 2018 10-K 03 Mar 2020 2019 FY
Q4 2017 $5,158,000 31 Dec 2017 10-K 19 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.